VOVerena Carola Obmann

Verena Carola Obmann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Verena Carola Obmann has a total of 273 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Fat Fraction Mapping in the Presence of Magnetic Field Inhomogeneities With Phase‐Cycled bSSFP at 3 T

    by Berk Can Acikgoz, Adèle L. C. Mackowiak, Giulia M. C. Bongiolatti‐Rossi, Annika Haeussler, Eva S. Peper, Jean‐Baptiste Ledoux, Verena C. Obmann, Adrian T. Huber, Naïk Vietti‐Violi, Tom Hilbert, et al.

    Magnetic field inhomogeneities (Δ B 0 ) can cause fat–water swaps in proton density fat fraction (PDFF) mapping using phase‐cycled balanced steady‐state free‐precession (bSSFP). In this work, a graph‐cuts–based smoothness‐imposing optimization was developed to estimate Δ B 0 from phase‐cycled bSSFP data obtained in fat–water compartments. Data were acquired in phantoms spanning PDFF of 0%–100% to quantify robustness to Δ B 0 and to determine the effect of RF excitation angle ( α ) on PDFF estimation. The approach was further tested in healthy volunteer knee data ( n = 9) and chronic liver disease patients data ( n = 5). Phase‐cycled bSSFP‐based Δ B 0 and PDFF maps were compared with multi‐echo gradient‐echo (MEGRE) reference maps in phantoms and knees. In liver patients, PDFF maps were compared visually and by retrospective ROI analysis with reference quantitative Dixon (qDixon) PDFF maps. Estimated Δ B 0 maps matched the reference, with a root‐mean‐squared error (RMSE) of 9 ± 2 Hz for a Δ B 0 range of ±400 Hz in phantoms and 17 ± 4 Hz for a range of ±150 Hz in knees. PDFF mapping accuracy improved after Δ B 0 correction, with mean RMSE reduced from 35% ± 9% to 3.55% ± 0.92% and mean R 2 increased from 0.29 ± 0.3 to 0.99 ± 0 ( p < 0.0001) across the six phantom experiments (mean ± SD of experiments). PDFF quantification showed significant bias for α = 5°, 40°, and 45° (bias = 2.7%, −2.9%, and −5.8%; p < 0.05), whereas no significant bias was observed for 10° ≤ α ≤ 35° ( p > 0.05). Mean PDFF differences versus MEGRE reference were 2.4% ± 3%, −0.1% ± 0.8%, and 0.2% ± 0.3% for muscle, subcutaneous fat, and bone marrow, respectively. In liver patients, whole‐liver ROI analysis demonstrated a mean PDFF difference of 3% relative to qDixon. Fat–water swaps were successfully removed in knee and patient liver PDFF maps. These results demonstrate that the proposed approach accurately estimates Δ B 0 and mitigates fat–water swaps in phantoms and healthy volunteer knees, while the patient liver study demonstrates the technical feasibility of the proposed framework for phase‐cycled bSSFP‐based PDFF mapping in vivo.

  • Open Access

    Liver MRI with T1 and T2 parametric mapping to characterize patients with primary sclerosing cholangitis

    by Adrian T. Huber, Samuel Erb, Marie Ardoino, Damiano Catucci, Michael Brönnimann, Lukas Zbinden, Kady Fischer, Dominik Paul Guensch, Annalisa Berzigotti, Lukas Ebner, et al.

    The diagnosis of primary sclerosing cholangitis remains difficult, particularly in the absence of typical bile duct strictures. This study aims to assess the diagnostic performance of MRI T1 and T2 mapping with regard to differentiating PSC patients from matched controls. In this IRB-approved study, we retrospectively included all patients with primary sclerosing cholangitis who underwent multiparametric MRI with T1 and T2 mapping (1.5T and/or 3T) between 09/2018–05/2020 at our institution. Sex-, age-, and field strength-matched patients were selected, without focal or diffuse liver disease and without significant liver steatosis, based on a proton density fat fraction 47 ms cut-off showed high sensitivity (89.7%) and moderate specificity (48.3%). For parametric T1 mapping at 3T, a >869 ms cut-off showed high specificity (89.2%) but lower sensitivity (40.5%). MRI T2 relaxation times were significantly increased in PSC patients both at 3T and 1.5T, while T1 relaxation time was significantly increased at 3T, but not at 1.5T. T2-weighted imaging at 1.5T demonstrated the highest diagnostic performance.

  • Rare Appearance of a Primary Hepatic Angiosarcoma of the Intrahepatic Portal Veins

    by Sandro Urs von Däniken, Charlotte Komarek, Matteo Montani, Verena C Obmann, Fabian Haupt

    Angiosarcoma of the liver is a rare malignant entity, accounting for approximately 2 % of all primary hepatic malignancies [1]. Clinical presentation as well as liver function tests are usually non-specific. Predisposing factors are often unknown, although exposure to certain chemicals such as Thorotrast, a formerly used radioactive contrast agent, has been implicated [2] [3]. Imaging findings on CT and MRI are non-specific and may overlap with those of other vascular or malignant hepatic tumors. Enhancement patterns are variable but typically demonstrate progressive contrast uptake in the delayed phase [4]. Pathologically, four different growth patterns have been described: multiple nodules, a giant mass, a large mass with nodules, and, rarely, a diffuse infiltrative micronodular pattern [4]. Owing to these non-specific imaging characteristics, hepatic angiosarcoma is frequently not recognized at initial imaging. Hepatic angiosarcoma is characterized by rapid progression and an overall poor prognosis, and standardized treatment strategies are lacking. Surgical resection has been shown to improve survival, potentially further enhanced by adjunctive chemotherapy in selected cases [1]. This case illustrates a rare infiltrative growth pattern along the intrahepatic portal veins, differing from the more commonly described nodular or mass-forming appearances of hepatic angiosarcoma [5] [6]. Received: 26 August 2025 Accepted after revision: 07 April 2026 Article published online: 23 April 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

  • Top Cited Papers
    Open Access

    International Multidisciplinary Consensus Report on Definitions, Diagnostic Criteria, and Management of Fatty Pancreas: A Joint Statement Endorsed by EPC, APA, EASD, EASL, ESGAR, ESGE, ESP, ESPCG, ESPEN, ESPGHAN, IAP, JPS, KPBA, LAPSG, and UEG

    by Miroslav Vujasinovic, Ihsan Ekin Demir, Giovanni Marchegiani, Peter Hegyi, Livia Archibugi, Roberto Valente, Gabriele Capurso, Heiko Witt, Stefanos Bonovas, Daniele Piovani, et al.

    This international, multidisciplinary consensus report represents the first effort to systematically define and characterize fatty pancreas. A key outcome of this endeavor was the recommendation to adopt “fatty pancreas” as the standardized and inclusive term to describe all forms of fat accumulation in the pancreas. This terminological consensus provides a critical foundation for unified reporting and clinical communication. Another major contribution of the report is the consensus on diagnostic imaging findings, which was based on radiological and endoscopic modalities. The proposed criteria aim to enhance consistency in clinical assessment and support the development of standardized research protocols. In addition to establishing terminology and diagnostic frameworks, the report also synthesizes current knowledge across a wide range of relevant domains. These include the etiology and epidemiology of fatty pancreas, as well as its associations with alcohol consumption, smoking, acute and chronic pancreatitis, pancreatic exocrine insufficiency, type 2 diabetes mellitus, and surgical outcomes. The potential links between fatty pancreas and neoplastic conditions such as intraductal papillary mucinous neoplasms and pancreatic cancer are also addressed, alongside the current understanding of its metabolic implications (beta‐cell function and glucose homeostasis) and treatment strategies. Throughout the consensus process, a consistent theme emerged: the limited availability of high‐quality, prospective clinical data. Therefore, many of the recommendations in this report are based on expert consensus rather than strong empirical evidence. As such, the statements require rigorous prospective validation before they can be adopted into routine clinical practice. This underscores a critical need for further research, particularly studies aimed at clarifying causal relationships, validating diagnostic tools, and determining the clinical relevance of fatty pancreas across diverse patient populations. This report serves as both a summary of our current understanding and a roadmap for future investigations, aiming to close existing knowledge gaps and guide evidence‐based clinical practice in this emerging field.


  • An Unusual Inguinal Mass in a 76-Year-old Patient With Suspected Cryptorchidism

    by Yana Terziyska, Verena Carola Obmann, José Antonio Rodriguez Calero, George N. Thalmann, Bernhard Kiss, Nicolas Arnold

  • Open Access

    Partial volume effect on kidney stones and lung nodules in CT imaging

    by Andreas Christe, Beat Roth, Daniel Guido Fuster, Karim Shakarchi, Dionysios Drakopoulos, Elias Primetis, Georgios Delimpasis, Adrian Thomas Huber, Verena Carola Obmann, Alan Arthur Peters, et al.

    Rationale and Objectives: To examine the impact of the partial volume effect (PVE) on the imaging of spherical objects depending on their size, density and center voxel position. Materials and Methods: We developed an algorithm for calculating the volume of a sphere wrapped by voxels. The algorithm measured the internal volume of each voxel cut by the sphere and automatically attributed the average voxel density. The sphere volume was simulated by the sum of voxels with an average density above the Hounsfield Unit (HU) cutoff level for that object. Various sphere sizes, densities and positions in the voxel grid were examined. The two clinical settings used were nodules (0 HU) in the lung (−1000 HU) and kidney stones (1000 HU) embedded in the renal parenchyma (30 HU). Results: Small kidney stones appeared magnified by the PVE when a stone cutoff level of 130 HU was used: the smallest stone simulated with a diameter of 1.4 mm demonstrated a volume that was 231% the size of the ground truth (sphere volume as measured with the classical formula). A hypothetical stone of 10 cm would still have a PVE of 2%. The PVE did not affect lung nodules if the cutoff level for the nodule fraction was set to the exact mean of both the internal and external density (−500 HU). Lung nodules were more affected by the geometrical effect, where tiny nodules appeared smaller because of the greater curvature of smaller spheres, often cutting less than 50% of the volume of a surface voxel. Conclusions: This study highlights the potential risks associated with inaccurate raw data postprocessing of CT images with objects that are particularly sensitive to the PVE, such as kidney stones and high-density calcifications (Agatston score).


  • Open Access

    The Association of Heart Failure and Liver T1 Mapping in Cardiac Magnetic Resonance Imaging

    by Adrian T. Huber, Joanna Bartkowiak, Robin Seitz, Benedikt Bernhard, Martina Boscolo Berto, Giancarlo Spano, Benedikt Wagner, Verena C. Obmann, Lukas Ebner, Inga A. S. Todorski, et al.

    Background/Objectives: The objective of this study was to investigate the association between congestive heart failure (CHF) and T1 mapping in both liver lobes using cardiac MRI. Methods: This retrospective study included patients who underwent cardiac MRI with T1 mapping sequences on a 1.5 T scanner. The liver T1 values were measured in four hepatic regions, utilizing cardiac short axis and four-chamber views. Echocardiographic and laboratory data were collected within 90 days of the cardiac MRI. Comparisons of the liver T1 values and echocardiographic parameters between patients with and without elevated NT-proBNP levels (>125 pg/mL) were conducted using the Mann–Whitney U test. Logistic regression models were employed to adjust for confounding factors. Results: A total of 397 patients were included (with a median age of 56 years; 127 females), of whom 35% (n = 138) exhibited elevated NT-proBNP levels. The patients with elevated NT-proBNP levels showed a larger end-diastolic volume (EDV: 92 vs. 81 mL/m2, p < 0.001) and a lower LVEF level (50% vs. 60%, p < 0.001). The liver T1 was significantly higher in the right liver lobe (670 vs. 596 ms, p < 0.001) and the caudate lobe (664 vs. 598 ms, p < 0.001), but not in the left lobe (571 vs. 568 ms, p = 0.068) or the dome (590 vs. 560 ms, p = 0.1). T1 mapping in the caudate (OR 1.013, 95% CI 1.004–1.023, p = 0.005) and right liver lobes (OR 1.012, 95% CI 1.003–1.021, p = 0.009) remained independently predictive in the logistic regression analysis. Conclusions: Elevated T1 values in the caudate and right liver lobes assessed by cardiac MRI were independently associated with CHF and outperformed T1 measurements in the left liver lobe in predicting disease.


  • Association of MRI-derived Segmental Nonfunctional Liver Volume and Chronic Liver Disease

    by Marie Ardoino, Lukas Zbinden, Jeremias B. Klaus, Alan Arthur Peters, Damiano Catucci, Michael Brönnimann, Annalisa Berzigotti, Lukas Ebner, Johannes T. Heverhagen, Andreas Christe, et al.

    To determine whether the nonfunctional liver volume (NFLV) is an indicator of chronic liver disease (CLD). Multiparametric 3T abdominal MRI examinations enhanced with gadobenate dimeglumine of 51 patients were included in the study and divided into two groups: patients with (n=20) and without (n=31) CLD. Pre- and postcontrast T1 relaxation times of the liver and aorta were measured in the T1 mapping sequences. Total and segmental liver volumes (Lvol) were determined using a convolutional neuronal network. The functional liver fraction (FLF) defined as [(1/T1liver postcontrast − 1/T1liver precontrast) ÷ (1/T1blood pool postcontrast − 1/T1blood pool precontrast)] × (1 − hematocrit) and the nonfunctional liver volume (NFLV) defined as (1 − FLF) × Lvol were calculated for the whole liver, segments I–III, and IV–VIII. Volumes, FLF, and NFLV were compared between the groups using the Mann-Whitney U test and receiver operation characteristics (ROC) analysis. Volumes were significantly higher in patients with CLD than without CLD for the whole liver (p<.01), segments I–III (p<.001), and segments IV–VIII (p<.01). No significant difference was found regarding FLF (p=.20–31). NFLV of the whole liver (p<.01), segments I–III (p<.001), and IV–VIII (p<.01) were significantly increased in patients with CLD. The highest AUCs were observed for Lvol (AUC=.80; p<.001) and NFLV (AUC=.78; p<.001), both in segments I–III. The optimal NFLV cutoff values for CLD were 745 ml for the whole liver (77 % sensitivity; 75% specificity), 174 ml for segments I–III (85% sensitivity; 70% specificity), and 573 ml for segments IV–VIII (77% sensitivity; 75% specificity). MRI-derived nonfunctional liver volume (NFLV) is helpful for early detection of imaging changes in CLD. NFLV is highly associated with CLD, notably when measured in the liver segments I–III. Überprüfen, ob das nicht-funktionelle Lebervolumen (NFLV) ein Indikator für chronische Lebererkrankung (CLD) ist. In die Studie wurden 51 multiparametrische 3T-MRT-Untersuchungen des Abdomens mit Gadobenatdimeglumin eingeschlossen und in zwei Gruppen aufgeteilt: Patienten mit (n=20) und ohne (n=31) CLD. Die T1-Relaxationszeiten von der Leber und Aorta vor und nach Kontrastmittelgabe wurden auf den T1 mapping sequences gemessen. Das Gesamtvolumen der Leber und die segmentalen Lebervolumina (Lvol) wurden mit einem Convolutional Neuronal Network bestimmt. Der funktionelle Leberanteil (FLF), definiert als [(1/T1Leber postkontrast − 1/T1Leber präkontrast) ÷ (1/T1Blutpool postkontrast − 1/T1Blutpool präkontrast)] × (1 − Hämatokrit) und das nichtfunktionelle Lebervolumen (NFLV), definiert als (1 − FLF) × Lvol, wurden für die gesamte Leber, Segmente I–III und IV–VIII berechnet. Lebervolumen, FLF und NFLV wurden mittels Mann-Whitney-U-Test und der ROC-Analyse (Receiver Operation Characteristics) zwischen den Gruppen verglichen. Das Volumen der Gesamtleber (p<.01), der Segmente I–III (p<.001) und der Segmente IV–VIII (p<.01) waren bei Patienten mit CLD signifikant höher als bei Patienten ohne CLD. Für die FLF wurde kein signifikanter Unterschied gefunden (p=.20–31). Die NFLV der gesamten Leber (p<.01), der Segmente I–III (p<.001) und IV–VIII (p<.01) waren bei Patienten mit CLD signifikant höher als bei Patienten ohne CLD. Die höchste AUC-Werte ergaben sich für Lvol (AUC=.80; p<.001) und NFLV (AUC=.78; p<.001), beide in den Segmenten I–III. Die optimalen Cutoff-Werte der NFLV für CLD waren 745 ml für die gesamte Leber (77% Sensitivität; 75% Spezifität), 174 ml für die Segmente I–III (85% Sensitivität; 70% Spezifität) und 573 ml für die Segmente IV–VIII (77% Sensitivität; 75% Spezifität). Das mittels MRT bestimmte, nicht-funktionelle Lebervolumen (NFLV) ist für die frühzeitige Erkennung von bildgebenden Veränderungen der CLD geeignet. Das NFLV ist in hohem Maße mit CLD assoziiert, vor allem wenn es in den Lebersegmenten I–III gemessen wird. Received: 29 July 2024 Accepted after revision: 08 January 2025 Article published online: 10 March 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

  • Open Access

    Cine-MRI for Quantifying Uterine Peristalsis: A Systematic Review and Meta-Analysis

    by Angela Vidal, Cristina Bora, Jeannette von Holzen, Marietta Gulz, Verena C. Obmann, Janna Pape, Tanya Karrer, Gürkan Yilmaz, Michael von Wolff

    Background: Uterine contractility, also known as uterine peristalsis (UP), is a critical determinant of fertility, affecting sperm transport and embryo implantation. Increased uterine peristaltic activity has been associated with reduced pregnancy rates. However, data are heterogeneous and uterine contractility has not been widely translated into clinical practice. Cine-MRI, although limited by cost and heterogeneity in data reporting, has emerged as a promising tool to assess uterine dynamics and increase our knowledge of UP in physiological and pathological conditions. Objective: This systematic review and meta-analysis aimed to describe patterns of UP in physiological and pathological uterine conditions, including endometriosis and fibroids, using cine-MRI. Methods: A systematic literature search of the Medline, Embase, Cochrane and CENTRAL databases and Google Scholar was conducted up to May 2024, including studies evaluating UP by cine-MRI. Clinical studies evaluating uterine contractility were included, excluding those affected by therapeutic interventions or unrelated pathologies. This meta-analysis pooled data from studies comparing uterine contractility in patients with endometriosis. Results: In the 13 included studies (365 women), uterine contractility varied significantly according to menstrual cycle phases and pathological conditions. This meta-analysis showed that women with endometriosis had higher uterine contractility in the luteal phase (0.74; 95% CI: 0.27–1.21) but not in the periovulatory phase (SMD 0.8; 95% CI: −3.78–5.37). Conclusions: Cine-MRI is a promising diagnostic tool for the analysis of UP. Endometriosis is associated with impaired UP, which may be a cause of the decreased implantation rate and infertility in endometriosis. However, further research is needed to consolidate the effect of UP on implantation and fertility and to develop standardised and cost-effective tools to assess uterine contractility and tailor infertility treatment.


  • Open Access

    MRI Dixon Fat-Corrected Look-Locker T1 Mapping for Quantification of Liver Fibrosis and Inflammation—A Comparison With the Non–Fat-Corrected Shortened Modified Look-Locker Inversion Recovery Technique

    by Jeremias Bendicht Klaus, Ute Goerke, Markus Klarhöfer, Mahesh Bharath Keerthivasan, Bernd Jung, Annalisa Berzigotti, Lukas Ebner, Justus Roos, Andreas Christe, Verena Carola Obmann, et al.

    Objectives: This study evaluates the impact of liver steatosis on the discriminative ability for liver fibrosis and inflammation using a novel Dixon water-only fat-corrected Look-Locker T1 mapping sequence, compared with a standard shortened Modified Look-Locker Inversion Recovery (shMOLLI) sequence, with the aim of overcoming the limitation of steatosis-related confounding in liver T1 mapping. Materials and Methods: 3 T magnetic resonance imaging of the liver including the 2 T1 mapping sequences and proton density fat fraction (PDFF) was prospectively performed in 24 healthy volunteers and 38 patients with histologically proven liver fibrosis evaluated within 90 days of liver biopsy. Paired Mann-Whitney test compared sequences between participants with and without significant liver steatosis (PDFF cutoff 10%), and unpaired Kruskal-Wallis test compared healthy volunteers to patients with early (F0–2) and advanced (F3–4) liver fibrosis, as well as low (A0–1) and marked (A2–3) inflammatory activity. Univariate and multivariate logistic regression models assessed the impact of liver steatosis on both sequences. Results: Dixon_W T1 was higher than shMOLLI T1 in participants without steatosis (median 896 ms vs 890 ms, P = 0.04), but lower in participants with liver steatosis (median 891 ms vs 973 ms, P < 0.001). Both methods accurately differentiated between volunteers and patients with early and advanced fibrosis (Dixon_W 849 ms, 910 ms, 947 ms, P = 0.011; shMOLLI 836 ms, 918 ms, 978 ms, P < 0.001), and those with mild and marked inflammation (Dixon_W 849 ms, 896 ms, 941 ms, P < 0.01; shMOLLI 836 ms, 885 ms, 978 ms, P < 0.001). Univariate logistic regression showed slightly lower performance of the Dixon_W sequence in differentiating fibrosis (0.69 vs 0.73, P < 0.01), compensated by adding liver PDFF in the multivariate model (0.77 vs 0.75, P < 0.01). Conclusions: Dixon water-only fat-corrected Look-Locker T1 mapping accurately identifies liver fibrosis and inflammation, with less dependency on liver steatosis than the widely adopted shMOLLI T1 mapping technique, which may improve its predictive value for these conditions.